RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (48)
High-efficiency transformation of mammalian cells by plasmid DNA.
1987 • 5,377 citations
Rho GTPases and signaling networks
1997 • 2,380 citations
Production of high-titer helper-free retroviruses by transient transfection.
1993 • 2,280 citations
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
1986 • 865 citations
Protein Prenyltransferases
1996 • 693 citations
Versatile retroviral vectors for potential use in gene therapy.
1994 • 690 citations
Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation
1991 • 576 citations
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
1999 • 538 citations
A role for Rho in Ras transformation.
1995 • 538 citations
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice
1995 • 533 citations
PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2
1999 • 440 citations
THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS
1997 • 329 citations
Effectors for the Rho GTPases
1999 • 327 citations
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.
1998 • 314 citations
Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?
1997 • 271 citations
Critical role of Rho in cell transformation by oncogenic Ras.
1995 • 256 citations
Cell Growth Inhibition by Farnesyltransferase Inhibitors Is Mediated by Gain of Geranylgeranylated RhoB
1999 • 255 citations
The Phosphoinositide 3-OH Kinase/AKT2 Pathway as a Critical Target for Farnesyltransferase Inhibitor-Induced Apoptosis
2000 • 244 citations
Evidence that Farnesyltransferase Inhibitors Suppress Ras Transformation by Interfering with Rho Activity
1995 • 220 citations
Non-Ras targets of farnesyltransferase inhibitors: focus on Rho
1998 • 214 citations
Farnesyltransferase Inhibitors Alter the Prenylation and Growth-stimulating Function of RhoB
1997 • 214 citations
Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilones
1998 • 212 citations
Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine.
1999 • 210 citations
Regulation of epidermal growth factor receptor traffic by the small GTPase RhoB
1999 • 199 citations
Farnesyltransferase Inhibition Causes Morphological Reversion of ras-Transformed Cells by a Complex Mechanism That Involves Regulation of the Actin Cytoskeleton
1994 • 197 citations
Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes.
1998 • 191 citations
Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment.
1997 • 184 citations
A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis
1998 • 173 citations
The ras-Related Gene rhoB Is an Immediate-Early Gene Inducible by v-Fps, Epidermal Growth Factor, and Platelet-Derived Growth Factor in Rat Fibroblasts
1991 • 162 citations
Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors.
1999 • 159 citations
The Ras-related Small GTP-binding Protein RhoB Is Immediate-early Inducible by DNA Damaging Treatments
1995 • 149 citations
Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.
1998 • 146 citations
Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton.
1994 • 142 citations
Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects
2000 • 138 citations
Loss of Matrix Adhesion Triggers Rapid Transformation-Selective Apoptosis in Fibroblasts
1997 • 135 citations
Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
1995 • 133 citations
The ras-related gene rhoB is an immediate-early gene inducible by v-Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts.
1991 • 115 citations
Farnesyltransferase inhibitors induce cytochrome c release and caspase 3 activation preferentially in transformed cells
1998 • 110 citations
Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells.
1994 • 109 citations
Activation of the PI3'K-AKT pathway masks the proapoptotic effects of farnesyltransferase inhibitors.
1999 • 105 citations
RhoB Is Stabilized by Transforming Growth Factor β and Antagonizes Transcriptional Activation
1998 • 101 citations
The epithelial cell default‐phenotype hypothesis and its implications for cancer
1997 • 93 citations
rhoB Encoding a UV-inducible Ras-related Small GTP-binding Protein Is Regulated by GTPases of the Rho Family and Independent of JNK, ERK, and p38 MAP Kinase
1997 • 79 citations
Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.
1999 • 69 citations
Inactivation of the small GTPase Rho disrupts cellular attachment and induces adhesion-dependent and adhesion-independent apoptosis
1997 • 65 citations
Inhibition of DNA Synthesis by a Farnesyltransferase Inhibitor Involves Inhibition of the p70s6k Pathway
1999 • 46 citations
Targeting farnesyltransferase: is Ras relevant?
1999 • 25 citations
Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
1999 • 17 citations
Cited By (0)
No citing papers found in database